Low-residue diet with oral nutritional supplements prior to colonoscopy improves the quality of bowel preparation: an endoscopist-blinded, randomized controlled trial.

Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X (Electronic) Linking ISSN: 1471230X NLM ISO Abbreviation: BMC Gastroenterol Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

Cathartics*/administration & dosage ; Colonoscopy*/methods ; Diet* ; Dietary Supplements*; Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Adenoma/diagnostic imaging ; Colonic Polyps/diagnostic imaging ; Single-Blind Method

Competing Interests: Declaration. Ethics approval and consent to participate: The study was conducted in strict adherence to the principles of the Declaration of Helsinki. The study was approved by the institutional review board of the Affiliated Hospital of Hangzhou Normal University (2022(E2)-HS-126). Written informed consent was obtained from all participants. Consent for publication: This is not applicable for this study. Competing interests: The authors declare no competing interests.
Background: Poor bowel preparation has been a great problem of endoscopists for a long time. Low-residue diet (LRD) is often recommended on the day before colonoscopy. However, the quality of bowel preparation with LRD alone is suboptimal. The aim of our study was to examine whether patients who consumed LRD with oral nutritional supplements (ONSs) had higher quality of bowel preparation than patients who consumed LRD alone before colonoscopy.
Methods: An endoscopist-blinded, randomized controlled trial was conducted in inpatients who scheduled for colonoscopy with sedation. Patients were randomized to the non-ONS group and the ONS group. The primary outcomes were the rates of adequate bowel preparation measured by the Boston Bowel Preparation Scale (BBPS), the Ottawa Bowel Preparation Scale (OBPS) and the Colon Endoscopic Bubble Scale (CEBuS). The secondary outcomes were the adenoma detection rate (ADR), polyp detection rate (PDR), intubation time, withdrawal time and rates of adverse events.
Results: In both groups, 100 patients were analyzed. The rates of adequate bowel preparation measured by the BBPS and OBPS and PDR were significantly higher in the ONS group than in the non-ONS group (all P < 0.05). However, no significant differences were observed in the CEBuS scores, ADR, intubation time and rates of adverse events between the two groups (all P > 0.05). The withdrawal time was longer in the non-ONS group than the in the ONS group (P < 0.05).
Conclusions: LRD with ONSs helps increase the quality of bowel preparation. To help with colorectal cancer (CRC) screening, further studies are warrant.
Trial Registration: [Chinese Clinical Trial Registry], [ChiCTR2400091660], [31/10/2024], [Retrospectively registered].
(© 2025. The Author(s).)

Scand J Gastroenterol. 2014 Apr;49(4):485-91. (PMID: 24495046)
Adv Nutr. 2015 Nov 13;6(6):820-7. (PMID: 26567203)
Nutrients. 2022 May 24;14(11):. (PMID: 35683980)
Gastroenterology. 2020 Mar;158(4):852-861.e4. (PMID: 31302144)
Pak J Med Sci. 2019 Nov-Dec;35(6):1516-1519. (PMID: 31777485)
JAMA. 2019 May 28;321(20):2040. (PMID: 31135851)
Endoscopy. 2019 Aug;51(8):775-794. (PMID: 31295746)
Dig Endosc. 2022 Sep;34(6):1121-1133. (PMID: 35294782)
Clin Gastroenterol Hepatol. 2021 Sep;19(9):1890-1898. (PMID: 33878471)
Gastrointest Endosc. 2004 Apr;59(4):482-6. (PMID: 15044882)
Compr Rev Food Sci Food Saf. 2022 Mar;21(2):843-867. (PMID: 35181994)
Can J Gastroenterol Hepatol. 2016;2016:3181459. (PMID: 27446836)
Gastrointest Endosc. 2016 Mar;83(3):499-507.e1. (PMID: 26460222)
Gut. 2023 Feb;72(2):338-344. (PMID: 36604116)
Endoscopy. 2022 Jan;54(1):45-51. (PMID: 33285583)
Gastroenterology. 2019 May;156(6):1661-1674.e11. (PMID: 30738046)
Gastrointest Endosc. 2021 Jan;93(1):77-85.e6. (PMID: 32598963)
J Acad Nutr Diet. 2012 Jun;112(6):960. (PMID: 22709819)
World J Gastroenterol. 2023 Mar 21;29(11):1685-1707. (PMID: 37077514)
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. (PMID: 38572751)
Gastrointest Endosc. 2009 Mar;69(3 Pt 2):620-5. (PMID: 19136102)
World J Gastroenterol. 2018 Jul 14;24(26):2833-2843. (PMID: 30018478)
JAMA. 2022 Jun 7;327(21):2114-2122. (PMID: 35670788)
Medicine (Baltimore). 2020 Dec 4;99(49):e23541. (PMID: 33285772)
Curr Gastroenterol Rep. 2020 May 6;22(6):28. (PMID: 32377915)
N Engl J Med. 2022 Oct 27;387(17):1547-1556. (PMID: 36214590)

Keywords: Bowel preparation; Low-residue diet; Oral nutritional supplements

0 (Cathartics)

Date Created: 20250313 Date Completed: 20250313 Latest Revision: 20250525

20250526

PMC11900647

10.1186/s12876-025-03751-z

40075287